GPCR position history
The shares of Structure Therapeutics (GPCR) that Avidity Partners Management LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2023 Q2: 37,800 shares, $1.6M, 0.05% of portfolio, New
- 2023 Q3: 500,000 shares, $25M, 1.0% of portfolio, Add +1222.8%
- 2023 Q4: 1,080,000 shares, $44M, 1.6% of portfolio, Add +116.0%
- 2024 Q1: 864,000 shares, $37M, 1.2% of portfolio, Reduce −20.0%
- 2024 Q2: 1,075,000 shares, $42M, 1.8% of portfolio, Add +24.4%
- 2024 Q3: 430,900 shares, $19M, 0.96% of portfolio, Reduce −59.9%
- 2024 Q4: not held, Exit
- 2025 Q1: not held
- 2025 Q2: not held
- 2025 Q3: not held
- 2025 Q4: not held
- 2026 Q1: 78,000 shares, $3.4M, 0.45% of portfolio, New
- 2026 Q2: 98,000 shares, $5.3M, 0.84% of portfolio, Add +25.6%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|